MARKET

OPTN

OPTN

Optinose
NASDAQ
6.00
+0.20
+3.45%
After Hours: 6.00 0 0.00% 16:05 03/19 EDT
OPEN
5.80
PREV CLOSE
5.80
HIGH
6.14
LOW
5.44
VOLUME
20.82K
TURNOVER
--
52 WEEK HIGH
31.50
52 WEEK LOW
4.815
MARKET CAP
60.33M
P/E (TTM)
-1.8620
1D
5D
1M
3M
1Y
5Y
1D
PARATEK PHARMACEUTICALS TO ACQUIRE OPTINOSE, CREATING SIGNIFICANT COMMERCIAL EXPANSION OPPORTUNITIES FOR XHANCE® IN CHRONIC RHINOSINUSITIS (CRS)
Reuters · 1h ago
PARATEK PHARMACEUTICALS - TOTAL TRANSACTION VALUE OF UP TO $330 MLN
Reuters · 1h ago
PARATEK PHARMACEUTICALS- POTENTIAL CONSIDERATION OF UP TO $14 PER SHARE, INCLUDING UPFRONT CONSIDERATION OF $9 PER SHARE
Reuters · 1h ago
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call
Barchart · 6h ago
OptiNose Inc <OPTN.OQ> expected to post a loss of 72 cents a share - Earnings Preview
Reuters · 1d ago
Weekly Report: what happened at OPTN last week (0310-0314)?
Weekly Report · 2d ago
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
Barchart · 03/11 15:15
Weekly Report: what happened at OPTN last week (0303-0307)?
Weekly Report · 03/10 09:13
More
About OPTN
OptiNose, Inc. is a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. The Company has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.

Webull offers OptiNose Inc stock information, including NASDAQ: OPTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPTN stock methods without spending real money on the virtual paper trading platform.